Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (44)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Park, J.
Right arrow Articles by Klaunig, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, J.
Right arrow Articles by Klaunig, J. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 65, 177-183 (2002)
Copyright © 2002 by the Society of Toxicology

CARCINOGENICITY

Acrylamide-Induced Cellular Transformation

Joungjoa Park, Lisa M. Kamendulis, Marvin A. Friedman and James E. Klaunig,1

Division of Toxicology, Department of Pharmacology and Toxicology, Indiana University School of Medicine, 635 Barnhill Dr., MS 1021, Indianapolis, Indiana 46202

Acrylamide is a monomer of polyacrylamide, whose products are used in biochemistry, the manufacture of paper, water treatment, and as a soil stabilizer. While polymeric acrylamide is nontoxic, the monomer can cause several toxic effects and has the potential for human occupational exposure. While acrylamide is not mutagenic in prokaryotic mutagenesis assays, chronic acrylamide treatment in rodents has been shown to produce tumors in both rats and mice. The mechanism for the induction of tumors by acrylamide is not known. In the present study, we examined the possibility that acrylamide might induce cellular transformation, using Syrian hamster embryo (SHE) cell morphological transformation as well as potential mechanisms for the cellular transformation. Results showed that treatment with 0.5 mM and higher concentrations of acrylamide continuously for 7 days induced morphological transformation. Cotreatment with acrylamide and N-acetyl-L-cysteine (NAC), a sulfhydryl group donor, resulted in the reduction of acrylamide-induced morphological transformation in SHE cells. Cotreatment with 1-aminobenzotriazole (ABT), a nonspecific P450 inhibitor, and acrylamide produced no change in morphological transformation when compared to acrylamide treatment only. Cotreatment with acrylamide and DL-buthionone-[S,R]-sulfoximine (BSO), a selective inhibitor of {gamma}-glutamylcysteine synthetase, increased the percent of morphologically transformed colonies compared to acrylamide treatment alone. Acrylamide reduced GSH levels in SHE cells, and cotreatment with acrylamide and NAC prevented the acrylamide-induced reduction of GSH. BSO treatment with acrylamide enhanced the depletion of GSH. These results suggest that acrylamide itself, but not oxidative P450 metabolites of acrylamide appear to be involved in acrylamide-induced cellular transformation and that cellular thiol status (possibly GSH) is involved in acrylamide-induced morphological transformation.

Key Words: acrylamide; carcinogenicity; oxidative stress; Syrian hamster embryo (SHE) cells; morphological transformation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Exp ToxicolHome page
B. Catalgol, G. Ozhan, and B. Alpertunga
Acrylamide-induced oxidative stress in human erythrocytes
Human and Experimental Toxicology, October 1, 2009; 28(10): 611 - 617.
[Abstract] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. G. Hogervorst, L. J. Schouten, E. J. Konings, R. A. Goldbohm, and P. A. van den Brandt
A Prospective Study of Dietary Acrylamide Intake and the Risk of Endometrial, Ovarian, and Breast Cancer
Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2304 - 2313.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
R. M. LoPachin, D. S. Barber, B. C. Geohagen, T. Gavin, D. He, and S. Das
Structure-Toxicity Analysis of Type-2 Alkenes: In Vitro Neurotoxicity
Toxicol. Sci., January 1, 2007; 95(1): 136 - 146.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. S. Felton and M. G. Knize
A meat and potato war: implications for cancer etiology
Carcinogenesis, December 1, 2006; 27(12): 2367 - 2370.
[Abstract] [Full Text] [PDF]

Home page
 International Journal of ToxicologyHome page
D. P. Arfsten, E. W. Johnson, A. R. Thitoff, A. E. Jung, E. R. Wilfong, S. M. Lohrke, T. A. Bausman, J. S. Eggers, and A. J. Bobb
Impact of 30-Day Oral Dosing with N-acetyl-L-cysteine on Sprague-Dawley Rat Physiology
International Journal of Toxicology, July 1, 2004; 23(4): 239 - 247.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.